Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (253)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Molecule	Drug Class / Mechanism	Oncology Type
Belinostat	HDAC Inhibitor	Hematologic (Lymphoma)
Molecule Belinostat Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Belzutifan	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Belzutifan Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Berzosertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Berzosertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Binimetinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Binimetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Bleximenib	EZH2 / Menin Inhibitor	Hematologic
Molecule Bleximenib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Bortezomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Bortezomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Bosutinib	BCR-ABL Tyrosine Kinase Inhibitor	Hematologic (Leukemia)
Molecule Bosutinib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Bozitinib	MET Inhibitor	Solid Tumour
Molecule Bozitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Brigatinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Brigatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Brigimadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Brigimadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Brivanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Brivanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Buparlisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Buparlisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor

Belinostat Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Belzutifan Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Berzosertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Binimetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Bleximenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism EZH2 / Menin Inhibitor
Bortezomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Bosutinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Leukemia) Drug Class / Mechanism BCR-ABL Tyrosine Kinase Inhibitor
Bozitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Brigatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Brigimadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Brivanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Buparlisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor

‹ 1 2 3 4 5 6 … 22 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (253)

Belinostat

Belzutifan

Berzosertib

Binimetinib

Bleximenib

Bortezomib

Bosutinib

Bozitinib

Brigatinib

Brigimadlin

Brivanib

Buparlisib

Belinostat

Belzutifan

Berzosertib

Binimetinib

Bleximenib

Bortezomib

Bosutinib

Bozitinib

Brigatinib

Brigimadlin

Brivanib

Buparlisib